lee suat ying
Skip Ribbon Commands
Skip to main content
Menu
Clin Asst Prof Lee Suat Ying

Clin Asst Prof Lee Suat Ying

​MBBS (Singapore), MRCP (UK)

Consultant

National Cancer Centre Singapore

Specialty: Medical Oncology

Sub-specialties: Gastrointestinal, Hepato-Pancreato-Biliary, Colorectal, Upper Gastrointestinal

Conditions Treated by this Doctor:
Oesophagus Cancer, Pancreatic Cancer, Stomach Cancer.

Clinical Appointments

  • Consultant Division of Medical Oncology National Cancer Centre SingaporeNational Cancer Centre Singapore

Academic Appointments

  • Clin Asst Prof, Duke-NUS Medical School

Profile

​Dr Lee Suat Ying graduated from NUS Yong Loo Lin School of Medicine in 2013, and went on to complete her Internal Medicine Junior Residency in Singhealth. She subsequently completed her Senior Residency in Medical Oncology in 2020 and has been practicing in the National Cancer Centre Singapore since as a member of the Gastrointestinal Oncology group.

Education

  • ​Completed Senior Residency in Medical Oncology in SHS in 2020
  • Obtained MRCP (UK) in 2016
  • Completed Junior Residency in Internal Medicine in SHS in 2016
  • Graduated in 2013 with MBBS from NUS YLLSoM

Professional Appointments and Committee Memberships

  • Core Faculty Member, Singhealth Medical Oncology Residency Programme
  • SSO member
  • ASCO member
  • ESMO member

Awards

​2017: Outstanding Senior Resident (RISE award)

Research Interests

Publications

  • Han, S.; Lee, S.Y (joint first author).; Wang, W.-W.; Tan, Y.B.; Sim, R.H.Z.; Cheong, R.; Tan, C.; Hopkins, R.; Connolly, J.; Shuen, W.H.; Toh, H.C. A Perspective on Cell Therapy and Cancer Vaccine in Biliary Tract Cancers (BTCs). Cancers 2020, 12, 3404. https://doi.org/10.3390/cancers12113404
  • Yuen J, Lee SY (joint first author), Courtney E, Lim J, Soh H, Li ST, et al. Evaluating empowerment in genetic counseling using patient-reported outcomes. Clin Genet. (2020) 97:246–56. doi: 10.1111/cge.13646
  • Yang SP, Ying LS, Saw S, Tuttle RM, Venkataraman K, Su-Ynn C. Practical Barriers to Implementation of Thyroid Cancer Guidelines in the Asia-Pacific Region. Endocr Pract. 2015 Nov;21(11):1255-68. doi: 10.4158/EP15850

Research Trials